Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

D&K Healthcare Resources Reports Record Q4 EPS of $0.56 and FY 2001 EPS of $2.02; Initiates FY 2002 Revenue and Earnings Guidance.


Business Editors

ST. LOUIS--(BUSINESS WIRE)--Aug. 9, 2001

D&K Healthcare Resources, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: DKWD DKWD Disk Write Data ) today reported record fourth quarter and full year net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
, EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become  and diluted earnings per share diluted earnings per share

An earnings measure calculated by dividing net income less preferred stock dividends for a period by the average number of shares of common stock that would be outstanding if all convertible securities were converted into shares of
 for the periods ended June June: see month.  30, 2001.

Summary Financial Results (in millions, except per share data)


                             Three Months Ended
                June 30, 2001        June 30, 2000            % Change
                -------------        -------------            --------
  Net sales        $ 449.3              $ 370.3                 + 21 %
  EBITDA             $ 8.1                $ 7.2                 + 13 %
  Net income         $ 2.6                $ 2.2                 + 18 %
  Diluted EPS       $ 0.56               $ 0.51                 + 10 %

                                  Year Ended
                June 30, 2001        June 30, 2000            % Change
                -------------        -------------            --------
  Net sales      $ 1,646.0            $ 1,458.0                 + 13 %
  EBITDA            $ 30.3               $ 25.3                 + 20 %
  Net income         $ 9.1                $ 8.2                 + 12 %
  Diluted EPS       $ 2.02               $ 1.84                 + 10 %


J. Hord Armstrong, III, Chairman and Chief Executive Officer commented, "By virtually any measure this was a record for both the fourth quarter and the year for D&K. In addition to generating the best operating results for these periods in D&K's history, we also completed a number of transactions which significantly expanded our capital and operating base, enabling us to capitalize To regard the cost of an improvement or other purchase as a capital asset for purposes of determining Income Tax liability. To calculate the net worth upon which an investment is based. To issue company stocks or bonds to finance an investment.  further on the significant growth trends we are experiencing in our industry.

"We completed a follow-on fol·low-on
adj.
Following as a related or consequent aspect or development: "Such contracts involve follow-on sales of maintenance services" Christian Science Monitor.
 public offering of D&K stock on July July: see month.  5th, raising $77 million in net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 for the Company as reflected in the accompanying ac·com·pa·ny  
v. ac·com·pa·nied, ac·com·pa·ny·ing, ac·com·pa·nies

v.tr.
1. To be or go with as a companion.

2.
 pro forma As a matter of form or for the sake of form. Used to describe accounting, financial, and other statements or conclusions based upon assumed or anticipated facts.

The phrase pro forma
 balance sheet. We also increased D&K's credit availability from $247 million to $300 million through the extension of two facilities arranged by units of FleetBoston Financial FleetBoston Financial was a Boston, Massachusetts-based bank created in 1999 by the merger of Fleet Financial Group and BankBoston. In 2004 it merged with Bank of America; all of its banks and branches were given the Bank of America logo.  and completed the acquisition of privately held Diversified diversified (di·verˑ·s  Healthcare, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, which we expect to be accretive to our earnings per share in its first full year as part of D&K."

Martin D. Wilson Wilson, city (1990 pop. 36,930), seat of Wilson co., E N.C., in a rich agricultural region; inc. 1849. It is a commercial and industrial center with a large tobacco market. Manufactures include textile goods (especially clothing), metal products, and processed foods. , President and Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
, added, "Our enhanced financial strength improves D&K's ability to invest in our existing operations and pursue other opportunities for growth. We have been successful in deploying capital into our national pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent.  chain and independent and regional pharmacy businesses, which were significant contributors in increasing our gross margin to 4.18% in FY 2001 from 3.87% the previous year as well as producing a 20% improvement in EBITDA.

"Additionally, Diversified Healthcare, which has a current run rate of nearly $200 million in annual net sales, expands our presence and distribution capabilities in solid markets while further building our customer base, principally among independent and regional pharmacy businesses."

Sales growth in the quarter was achieved primarily in the national pharmacy chain business; the independent and regional pharmacy trade class also achieved above average gains. National pharmacy chain sales increased $79.3 million, or 56%, over the same period of fiscal 2000, reflecting D&K's specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 expertise, capabilities and infrastructure. Sales to independent and regional pharmacies This article is a list of major pharmacies (also known as chemists and drugstores) by country. Australia
Pharmacies in Australia are mostly independently-owned by pharmacists, often operated as franchises of retail brands offered by the three major
 increased $33.1 million, or 19.6% in the fourth quarter, over the fourth quarter of fiscal 2000, reflecting growing demand in this trade class and D&K's attention to the personalized per·son·al·ize  
tr.v. per·son·al·ized, per·son·al·iz·ing, per·son·al·iz·es
1. To take (a general remark or characterization) in a personal manner.

2. To attribute human or personal qualities to; personify.
 service it requires. Sales to other healthcare providers declined 56.7% in the fourth quarter to $25.5 million. The decrease was due principally to the loss of sales from two mail order accounts that ended in the fourth quarter of FY 2000. The accounts had contributed net sales of $39 million in the fourth quarter of 2000 and $335 million in fiscal 2000.

Net interest expense was essentially flat in the fourth quarter at $2.9 million as an increase in weighted average borrowings was offset by a decrease in interest rates.

Thomas (language) Thomas - A language compatible with the language Dylan(TM). Thomas is NOT Dylan(TM).

The first public release of a translator to Scheme by Matt Birkholz, Jim Miller, and Ron Weiss, written at Digital Equipment Corporation's Cambridge Research Laboratory runs
 S. Hilton Hil·ton   , Conrad Nicholson 1887-1979.

American hotel-chain organizer who acquired hotels in many American cities and in 1946 founded the Hilton Hotel Corporation.
, Senior Vice President and Chief Financial Officer commented, "In addition to strong operating trends, D&K continues to benefit from lower interest rates, which on a weighted average basis declined 111 basis points in the fourth quarter versus the same quarter last year. Factoring in the impact from the newly issued shares, a 25 basis point reduction in rates now improves our annual EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  by $0.02 to $0.03 per share."

Fiscal 2002 Revenue and Earnings Guidance

Mr. Hilton added, "Looking forward to fiscal 2002, we are currently targeting net sales of $2.3 billion for the full year, a projected 39% improvement over fiscal 2001. Given the mix of business that we anticipate for the upcoming year, we expect our gross margins to be approximately 4.2% for the year, allowing for some quarterly fluctuations. We are projecting fiscal 2002 EPS of at least $2.40, with approximately 60% of our earnings being generated in the second half of the year, which includes our seasonally strongest third quarter. Due to an approximate ap·prox·i·mate
v.
To bring together, as cut edges of tissue.

adj.
1. Relating to the contact surfaces, either proximal or distal, of two adjacent teeth; proximate.

2. Close together.
 50% increase in total shares outstanding as a result of the public offering, we expect earnings per share of $0.35 to $0.37 in the first quarter of fiscal 2002, approximating fiscal 2001 Q1 earnings of $0.36 per share."

About D&K Healthcare Resources

With fiscal 2001 revenues of $1.65 billion, St. Louis-based D&K Healthcare Resources, Inc., is a wholesale distributor of pharmaceutical and related healthcare and beauty aid products to independent and regional pharmacies, national pharmacy chains and other healthcare providers. D&K currently services customers in 24 states primarily in the Midwest Midwest or Middle West, region of the United States centered on the western Great Lakes and the upper-middle Mississippi valley. It is a somewhat imprecise term that has been applied to the northern section of the land between the Appalachians  and South from distribution facilities in Cape Girardeau Cape Girardeau (jĭrär`dō, jērərdō`), city (1990 pop. 61,633), Cape Girardeau co., SE Mo., overlooking the Mississippi River; founded 1793, inc. as a city 1843. , MO; Davie Da·vie  

A town of southeast Florida southwest of Fort Lauderdale. It is in a citrus-growing area. Population: 79,800.
, FL; Lexington Lexington.

1 City (1990 pop. 225,366), seat of Fayette co., N central Ky., in the heart of the bluegrass region; inc. 1832, made coextensive with Fayette co. 1974.
, KY; Minneapolis Minneapolis (mĭn'ēăp`əlĭs), city (1990 pop. 368,383), seat of Hennepin co., E Minn., at the head of navigation on the Mississippi River, at St. Anthony Falls; inc. 1856. , MN; Aberdeen Aberdeen, former county, Scotland
Aberdeen, former county, Scotland: see Aberdeenshire.
Aberdeen, city, Scotland
Aberdeen, city (1991 pop.
, SD; and through its recent acquisition of Diversified Healthcare LLC, in Owensboro Owensboro, city (1990 pop. 53,549), seat of Daviess co., W Ky., on the Ohio River; settled c.1800, inc. as a city 1866. It is an important tobacco market and a shipping point for a farm and oil region. , KY. D&K also offers a variety of additional services to its customers, including inventory management, services designed to contain costs, information technology systems and various marketing programs related to generic pharmaceuticals and other products. In addition, D&K owns a 68% equity interest in Pharmaceutical Buyers, Inc., a recognized alternate-site group purchasing organization A group purchasing organization is an entity that leverages the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO members. Many GPOs are funded by administrative fees that are actually paid by the vendors. . D&K invites you to visit its Web site at http://www.dkwd.com.

Conference Call / Web Cast Notification

D&K Healthcare Resources' fourth quarter conference call will take place today, Thursday Thursday: see week. , August 9, at 10:30 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
. A webcast and replay will be available at www.dkwd.com/irevents.htm.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Provisions

This press release may contain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward-looking statements are inherently subject to risks and uncertainties. D&K's actual results could differ materially from those currently anticipated due to a number of factors, including without limitation, the competitive nature of the wholesale pharmaceutical distribution industry, with many competitors having substantially greater resources than D&K, and D&K's customers generally having the right to terminate Terminate (terminat.exe) was a shareware modem terminal and host program for MS-DOS and compatible operating systems developed from the early to the late 1990s by the Dane Bo Bendtsen. The last release (5.  or reduce their purchases on relatively short notice, the changing business and regulatory reg·u·late  
tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates
1. To control or direct according to rule, principle, or law.

2.
 environment of the healthcare industry in which D&K operates, changes in interest rates and other factors set forth in reports and other documents filed by D&K with the Securities and Exchange Commission from time to time. D&K undertakes no obligation to publicly update or revise any forward-looking statements.


                    D&K Healthcare Resources, Inc.
                 Condensed Consolidated Balance Sheet

                            (In thousands)



                      (Unaudited)
                       Pro Forma
                     June 30, 2001 (1)  June 30, 2001    June 30, 2000
Assets
Cash                       $    9,006      $    7,516       $    3,661
Accounts receivable            46,419          45,131           29,923
Inventories                   214,739         214,739          202,467
Other current
 assets                         2,820           2,664            1,443
                        --------------   -------------   -------------
   Total current
    assets                    272,984         270,050          237,494
                        --------------   -------------  --------------
  Property and
   equipment, net              11,076          10,915            8,184
Investment in affiliates          954           5,506            5,199
Other assets                   54,308          43,784           43,542
                        -------------- --------------   --------------
   Total assets             $ 339,322     $   330,255      $   294,419
                        ==============   =============  ==============

Liabilities and
 stockholders'
  equity
Accounts payable          $   158,985     $   158,949      $   134,834
Current portion
 long-term debt                 1,242             320              305
Other current
 liabilities                   14,073          13,367            8,799
                        --------------   -------------  --------------
   Total current
    liabilities               174,300         172,636          143,938
Long-term liabilities           2,232           2,232              700
Long-term debt                 20,862          94,489           99,647
Deferred income taxes           3,388           3,388            4,869
Stockholders' equity          138,540          57,510           45,265
                        -------------- --------------   --------------
   Total liabilities and
    stockholders' equity  $   339,322     $   330,255      $   294,419
                        ==============   =============  ==============

(1)  Reflects net proceeds from the sale of 2,445,797 shares of common
     stock in a public offering as well as the issuance of 180,000
     shares of common stock in exchange for an additional 18% equity
     stake in Pharmaceutical Buyers, Inc. The public offering was
     completed July 5, 2001.


                    D&K Healthcare Resources, Inc.
            Condensed Consolidated Statement of Operations
                 (In thousands, except per share data)



                              June 30,        % of             June 30,
                                               Net
                                 2001         Sales              2000
                        ---------------- ------------ ----------------

Net sales                      $ 449,347      100.00%        $ 370,348
Cost of sales                    431,112       95.94%          354,376
                            ------------              ----------------

   Gross profit                   18,235        4.06%           15,972

Operating expenses                10,983        2.44%            9,558
                            ------------              ----------------

   Income from
    operations                     7,252        1.61%            6,414

Other income (expense):
   Interest expense, net          (2,948)      -0.66%           (2,923)
   Other, net                         40        0.01%              187
                            ------------              ----------------

Pretax earnings                    4,344        0.97%            3,678
Income tax provision               1,719        0.38%            1,457
                            ------------              ----------------

Net income                       $ 2,625        0.58%          $ 2,221
                            ============              ================

EBITDA                           $ 8,121        1.81%          $ 7,180

Basic earnings per
 share                           $  0.62                       $  0.53
Diluted earnings
 per share                       $  0.56                       $  0.51

EBITDA per diluted share         $  1.74                       $  1.62

Basic common shares
 outstanding                       4,266                         4,186
Diluted common shares
 outstanding                       4,673                         4,443

                                                  % of             %
                                              Net Sales         Change

                                            ------------   -----------

Net sales                                        100.00%          21.3%
Cost of sales                                     95.69%          21.7%


   Gross profit                                    4.31%          14.2%

Operating expenses                                 2.58%          14.9%


 Income from
  operations                                       1.73%          13.1%


Other income (expense):
   Interest expense, net                          -0.79%           0.9%
   Other, net                                      0.05%         -78.6%



Pretax earnings                                    0.99%          18.1%
Income tax provision                               0.39%          18.0%


Net income                                         0.60%          18.2%


EBITDA                                             1.94%          13.1%


EPS calculation:     Three months ended            Three months ended
                       June 30, 2001                 June 30, 2000

                 Income  Shares   Per Share  Income   Shares Per Share
                 ------  ------   ---------  ------  ------  ---------
Basic earnings

 per share:

Net income

 available to
  common

  shareholders   $  2,625   4,266 $  0.62  $  2,221   4,186    $  0.53
Effect of
 diluted
  securities:
Options and
 warrants               -     207                 -      57
Convertible
 PBI stock              1     200                38     200
                --------- -------           ------- --------

Diluted
 earnings
 per share:
Net income
 available
 to common
  shareholders
   plus
 assumed
  conversions    $  2,626   4,673 $  0.56 $  2,259   4,443     $  0.51
                ========= =======          ======== =======


                    D&K Healthcare Resources, Inc.
            Condensed Consolidated Statement of Operations
                 (In thousands, except per share data)

                                           Twelve Months Ended

                                June 30,       % of            June 30,
                                   2001    Net Sales             2000
                       ----------------- ------------- ---------------

Net sales                   $ 1,645,993       100.00%      $ 1,458,047
Cost of sales                 1,577,169        95.82%        1,401,625
                           -------------                --------------

   Gross profit                  68,824         4.18%           56,422

Operating expenses               41,878         2.54%           34,123
                           -------------                --------------

   Income from
    operations                   26,946         1.64%           22,299

Other income (expense):
   Interest expense, net        (11,959)       -0.73%           (9,636)
   Other, net                        44         0.00%              736
                           -------------                --------------

Pretax earnings                  15,031         0.91%           13,399
Income tax provision              5,887         0.36%            5,200
                           -------------                --------------

Net income                      $ 9,144         0.56%          $ 8,199
                           =============                ==============

EBITDA                         $ 30,324         1.84%         $ 25,342

Basic earnings
 per share                      $  2.16                        $  1.93
Diluted earnings
 per share                      $  2.02                        $  1.84

EBITDA per diluted
 share                          $  6.64                        $  5.57

Basic common shares
 outstanding                      4,239                          4,241
Diluted common shares
 outstanding                      4,566                          4,550

                                                 % of              %
                                              Net Sales        Change
                                            ----------- --------------

Net sales                                        100.00%          12.9%
Cost of sales                                     96.13%          12.5%


   Gross profit                                    3.87%          22.0%

Operating expenses                                 2.34%          22.7%


   Income from operations                          1.53%          20.8%

Other income (expense):
   Interest expense, net                           -0.66%         24.1%
   Other, net                                       0.05%        -94.0%



Pretax earnings                                    0.92%          12.2%
Income tax provision                               0.36%          13.2%


Net income                                         0.56%          11.5%


EBITDA                                             1.74%          19.7%




EPS calculation:     Twelve months ended       Twelve  months ended

                       June 30, 2001              June 30, 2000

                    Income  Shares Per Share Income   Shares Per Share

                    ------  -----  --------- -------  ------ ---------

Basic earnings

 per share:

Net income

 available to

  common

   shareholders    $  9,144  4,239  $  2.16 $  8,199    4,241  $  1.93

Effect of diluted
 securities:
Options and
 warrants                 -    127                 -      109

Convertible
 PBI stock               95    200               152      200

                   -------- -------         --------  -------

Diluted earnings
 per share:
Net income
 available
  to common

   shareholders
    plus
     assumed
      conversions  $  9,239  4,566  $  2.02 $  8,351    4,550  $  1.84

                   ======== =======         ======== ========

COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 9, 2001
Words:2017
Previous Article:Trex Decking Named Brand Leader by Remodeling Magazine.
Next Article:HarmonyCOM to Showcase Provisioning Software At the MetaSolv Executive Business Center.
Topics:



Related Articles
McKesson Reports Record Income, Up 67%, in Third Quarter; Growth Is Driven by 80% Increase in Health Care Profit.
SPSS Inc. Releases First Quarter and Fiscal Year 2001 Guidance.
D&K Healthcare Resources Achieves Record Quarterly Net Sales of $529 Million and Record Q1 EPS of $0.50; D&K Raises FY 2002 EPS Guidance to $2.60...
MGAM Announces FY 2001 EPS.
D&K Healthcare Resources Achieves All-Time Record Quarterly Net Sales of $592 Million and Record Q2 EPS Of $0.62.
D&K Healthcare Q3 Revenue Increases 42% And EPS Rise 40%; Posts All-time Quarterly Revenue, EBITDA, Net Income And EPS Records.
Imation Corp. Historical Information.
D&K Healthcare FY 2002 EPS Rise 41% to a Record $1.42 On a Record $2.45 Billion in Net Sales, a 49% Increase.
D&K Healthcare Resources Reduces Q1 EPS Guidance On Lower Than Expected Q1 Sales - To Host Conference Call/Webcast Today.
D&K Healthcare Resources Reports Q2 Fiscal 2003 Results and Updates Full-Year Guidance.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles